Journal article

An Online, Person-Centered, Risk Factor Management Program to Prevent Cognitive Decline: Protocol for A Prospective Behavior-Modification Blinded Endpoint Randomized Controlled Trial

YY Lim, D Ayton, S Perin, A Lavale, N Yassi, R Buckley, C Barton, L Bruns, R Morello, S Pirotta, E Rosenich, SMW Rajaratnam, R Sinnott, A Brodtmann, AI Bush, P Maruff, L Churilov, A Barker, MP Pase

Journal of Alzheimer S Disease | IOS PRESS | Published : 2021

Abstract

Background: Several modifiable risk factors for dementia have been identified, although the extent to which their modification leads to improved cognitive outcomes remains unclear. Objective: The primary aim is to test the hypothesis that a behavior modification intervention program targeting personalized risk factors prevents cognitive decline in community-dwelling, middle-aged adults with a family history of dementia. Methods: This is a prospective, risk factor management, blinded endpoint, randomized, controlled trial, where 1510 cognitively normal, community-dwelling adults aged 40-70 years old will be recruited. Participants will be screened for risk factors related to vascular health (..

View full abstract

Grants

Awarded by National Institute on Aging


Funding Acknowledgements

This trial is funded by a National Health and Medical Research (NHMRC) Boosting Dementia Research Initiative grant (GNT1171816). YY Lim is supported by an NHMRC Career Development Fellowship (GNT1162645). D Ayton is supported by an NHMRC Investigator Grant (GNT1195357). M Pase is supported by a Heart Foundation Future Leader Fellowship (GNT102052). R Buckley is supported by a ational Institutes of Health K99R00 award (K99AG061238). Participants will be recruited from the Healthy Brain Project (healthybrainproject.org.au) and from the community. The Healthy Brain Project is managed by YY Lim, M Pase, N Yassi and R Buckley, and is funded by the National Health and Medical Research Council (GNT1158384, GNT1147465, GNT1111603, GNT1105576, GNT1104273), the Alzheimer's Association (AARG-17-591424, AARG-18-591358, AARG-19-643133), the Dementia Australia Research Foundation, the Bethlehem Griffiths ResearchFoundation, the Yulgilbar Alzheimer's Research Program, the National Heart Foundation of Australia (102052), and the Charleston Conference for Alzheimer's Disease.